More on ICU
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.06 |
|
|||
| Open | $3.10 | ||||
| 52 Wk High | $1.99 | ||||
| 52 Wk Low | $1.99 | ||||
| Day High | $3.16 | ||||
| Day Low | $2.84 | ||||
| P/E | 11.60 | ||||
| EPS | $0.25 | ||||
| Volume | 141,554 | ||||
- SeaStar Medical CMO named 2026 Combat Nephrology Award recipient
- SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
- Form D SeaStar Medical Holding
- FDA grants SeaStar Medical breakthrough device status for sepsis therapy
- FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
- Form 8-K SeaStar Medical Holding For: Oct 05
- SeaStar Medical raises $3.3M through warrant exercise at reduced price
- SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
- SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
- New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)
Entities mentioned with ICU
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- S3 | View Related Stories »
- Earnings | View Related Stories »
- Show More...
